Maximum quantity allowed is 999
CAS RN: 85416-73-5 | Product Number: R0183
(S)-(+)-Rolipram
Purity: >98.0%(HPLC)
- (S)-(+)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
10MG |
₹6,000.00
|
1 | 28 |
|
50MG |
₹26,100.00
|
Contact Us | 19 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | R0183 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__6H__2__1NO__3 = 275.35 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 85416-73-5 |
Reaxys Registry Number | 6687797 |
PubChem Substance ID | 354333407 |
MDL Number | MFCD03093861 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Optical purity(LC) | min. 97.0 ee% |
Elemental analysis(Nitrogen) | 4.50 to 5.50 % |
Melting point | 132.0 to 136.0 °C |
Specific rotation [a]20/D | +29.0 to +34.0 deg(C=0.5, MeOH) |
NMR | confirm to structure |
Melting Point | 134 °C |
Specific Rotation | 32° (C=0.5,MeOH) |
References
- Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase
- Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
- Multistep continuous-flow synthesis of (R)- and (S)-rolipram using heterogeneous catalysts
- Flow “Fine” Synthesis: High Yielding and Selective Organic Synthesis by Flow Methods
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.